| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/11/2013 | US20130089903 Use of inducible promoters in the production of glycolic acid |
| 04/11/2013 | US20130089894 Methods For Increasing Homologous Recombination Of A Nucleic Acid Sequence |
| 04/11/2013 | US20130089892 Yeast strains modified in their sophorolipid production and uses thereof |
| 04/11/2013 | US20130089653 New cucumber variety nun 5539 cup |
| 04/11/2013 | US20130089569 Recombinant mva capable of expressing structural hcv antigens |
| 04/11/2013 | US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 04/11/2013 | US20130089558 Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/11/2013 | US20130089557 Antibody specifically binding to epitope in sema domain of c-met |
| 04/11/2013 | US20130089553 Method for making heteromultimeric polypeptides |
| 04/11/2013 | US20130089552 Acylglycerol acyltransferase-like protein mgat-x1 and uses thereof |
| 04/11/2013 | US20130089548 Method and compositions to induce apoptosis of tumoral cells expressing shh |
| 04/11/2013 | US20130089542 Anti c-met antibody and uses thereof |
| 04/11/2013 | US20130089523 Adenovirus derived helper virus for enhancing recombinant parvovirus production |
| 04/11/2013 | US20130089522 Heterologous hosts |
| 04/11/2013 | DE102011114914A1 Transgene pflanze der art beta vulgaris mit gesteigerter resistenz gegenüber cercospora The transgenic plant of the type beta vulgaris with increased resistance against Cercospora |
| 04/11/2013 | CA2851251A1 Simian (gorilla) adenovirus or adenoviral vectors and methods of use |
| 04/11/2013 | CA2851231A1 Hibiscus cannabinus feruloyl-coa:monolignol transferase |
| 04/11/2013 | CA2850792A1 Compositions and methods for silencing aldehyde dehydrogenase |
| 04/11/2013 | CA2850629A1 Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| 04/11/2013 | CA2850627A1 Affenadenovirus (gorilla) or adenoviral vectors and methods of use |
| 04/11/2013 | CA2850624A1 Modified nucleosides, nucleotides, and nucleic acids, and uses thereof |
| 04/11/2013 | CA2850571A1 Nicotiana benthamiana plants deficient in fucosyltransferase activity |
| 04/11/2013 | CA2850490A1 Wheat with increased resistant starch levels |
| 04/11/2013 | CA2850274A1 Ecm composition, tumor microenvironment platform and methods thereof |
| 04/11/2013 | CA2850223A1 Control of whole body energy homeostasis by microrna regulation |
| 04/11/2013 | CA2849920A1 Methods and compositions for regulating hiv infection |
| 04/11/2013 | CA2849856A1 Regulatable promoter |
| 04/11/2013 | CA2844868A1 Rnai for the control of fungi and oomycetes by inhibiting saccharopine dehydrogenase gene |
| 04/10/2013 | EP2578699A1 Methods for detection of risk of obesity and risk of onset of diabetes |
| 04/10/2013 | EP2578692A1 Agents that reduce neuronal overexcitation |
| 04/10/2013 | EP2578688A1 ADAM6 mice |
| 04/10/2013 | EP2578687A1 Seed-preferred gene promotors from the castor plant |
| 04/10/2013 | EP2578686A1 Plants having enhanced yield-related traits and a method for making the same |
| 04/10/2013 | EP2578685A2 RNA containing modified nucleosides and methods of use thereof |
| 04/10/2013 | EP2578684A1 Antagonists of ligands and uses thereof |
| 04/10/2013 | EP2578683A1 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 04/10/2013 | EP2578682A1 Antibody and use thereof |
| 04/10/2013 | EP2578681A1 Iga-binding peptide and iga purification using same |
| 04/10/2013 | EP2578678A1 Method for producing tumor cell |
| 04/10/2013 | EP2578603A1 B cell activating factor antagonist and preparation method and use thereof |
| 04/10/2013 | EP2578236A1 PREPARATION OF MICROVESICLE-siRNA COMPLEXES AND USE THEREOF IN AIDS TREATMENT |
| 04/10/2013 | EP2576839A2 Nucleic acid detection and quantification by post-hybridization labeling and universal encoding |
| 04/10/2013 | EP2576838A2 Methods for improving inflammatory bowel disease diagnosis |
| 04/10/2013 | EP2576832A2 Compositions and methods for detecting a neoplasia |
| 04/10/2013 | EP2576808A1 Novel reporter constructs for compound screening |
| 04/10/2013 | EP2576807A2 Fast screening of clones |
| 04/10/2013 | EP2576800A2 Tailored oils produced from recombinant heterotrophic microorganisms |
| 04/10/2013 | EP2576799A1 Production of fatty acids by heterologous expression of gene clusters from myxobacteria |
| 04/10/2013 | EP2576798A2 Tailored recombinase for recombining asymmetric target sites in a plurality of retrovirus strains |
| 04/10/2013 | EP2576797A1 Protein body-inducing polypeptide sequences |
| 04/10/2013 | EP2576796A1 Filamentous fungal host strains and dna constructs, and methods of use thereof |
| 04/10/2013 | EP2576795A1 A method for producing a polypeptide in yarrowia lipolytica |
| 04/10/2013 | EP2576794A2 Improved production of proteins in filamentous fungi |
| 04/10/2013 | EP2576793A1 Method for improved protein production in filamentous fungi |
| 04/10/2013 | EP2576792A2 Method for protein production in filamentous fungi |
| 04/10/2013 | EP2576791A1 Methods and compositions using listeria for adjuvant treatment of cancer |
| 04/10/2013 | EP2576790A1 Vitronectin:keratinocyte growth factor chimeras |
| 04/10/2013 | EP2576789A2 Novel modified live-attenuated vaccines (mlv) and subunit vaccines created by dna shuffling against porcine reproductive and respiratory syndrome virus (prrsv) |
| 04/10/2013 | EP2576788A2 Cloning and exploitation of a functional r-gene from solanum x edinense |
| 04/10/2013 | EP2576787A1 Snps associated with polycystic ovary syndrome, chips comprising the same and use thereof |
| 04/10/2013 | EP2576786A1 High-affinity nucleic acid aptamers against sclerostin protein |
| 04/10/2013 | EP2576785A2 Regulation of metabolism by mir-378 |
| 04/10/2013 | EP2576784A2 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra |
| 04/10/2013 | EP2576783A2 Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1 |
| 04/10/2013 | EP2576782A1 Sirna and their use in methods and compositions for the treatment and/or prevention of eye conditions |
| 04/10/2013 | EP2576781A2 Composition and method for inner ear sensory hair cell regeneration and replacement |
| 04/10/2013 | EP2576780A1 Method for the preparation and amplification of representative and strand- specific libraries of cdna for high throughput sequencing, use thereof, kit and cartridges for automation kit |
| 04/10/2013 | EP2576779A1 Method for isolating and/or purifying nucleic acid(s) |
| 04/10/2013 | EP2576778A1 Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organisms |
| 04/10/2013 | EP2576777A2 Ideotypically modulated pharmacoeffectors for selective cell treatment |
| 04/10/2013 | EP2576776A1 Modified beta-lactamases and methods and uses related thereto |
| 04/10/2013 | EP2576775A1 Modified cellulases with enhanced thermostability |
| 04/10/2013 | EP2576774A2 Modified rnase h and detection of nucleic acid amplification |
| 04/10/2013 | EP2576773A2 Methods and helper viruses for the generation of rna virus |
| 04/10/2013 | EP2576772A1 Antigen-presenting modified naïve b cells for immune suppression and a method for producing said modified cells |
| 04/10/2013 | EP2576626A2 Stable, functional chimeric cellobiohydrolase class i enzymes |
| 04/10/2013 | EP2576625A2 Fusion protein having factor vii activity |
| 04/10/2013 | EP2576624A1 Recombinant human g-csf dimer and use thereof for the treatment of neurological diseases |
| 04/10/2013 | EP2576607A1 Means for the transient production in plants of recombinant proteins that can be used in particular in prophylaxis and in therapeutics |
| 04/10/2013 | EP2576605A2 Production of metabolites |
| 04/10/2013 | EP2576604A1 Diffocins and methods of use thereof |
| 04/10/2013 | EP2576581A1 Recombinant rna viruses and uses thereof |
| 04/10/2013 | EP2576580A2 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase |
| 04/10/2013 | EP2576579A2 Compositions and methods directed to treating liver fibrosis |
| 04/10/2013 | EP2575894A1 Delivery of lentiviral vectors to the brain |
| 04/10/2013 | EP2575883A2 Treatment of inflammatory disorders |
| 04/10/2013 | EP2575852A1 Antimicrobial peptides and peptide derivatives derived from oncopeltus fasciatus |
| 04/10/2013 | EP2575767A1 Novel low molecular weight cationic lipids for oligonucleotide delivery |
| 04/10/2013 | EP2575764A2 Biodegradable lipids for the delivery of active agents |
| 04/10/2013 | EP2575439A1 Fusion proteins comprising a dna-binding domain of a tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| 04/10/2013 | EP2575433A2 Energy saving brewing method |
| 04/10/2013 | EP2575432A1 Recombinant production of steviol glycosides |
| 04/10/2013 | EP2575431A1 Transgenic brassica event mon 88302 and methods of use thereof |
| 04/10/2013 | EP2575430A1 Plants with increased fruit size |
| 04/10/2013 | EP2575429A1 Method for increasing plant biomass |
| 04/10/2013 | CN103038367A Compositions, kits, and methods for synthesis and/or detection of nucleic acids |
| 04/10/2013 | CN103038358A Method of manufacturing zeaxanthin by fermentation |
| 04/10/2013 | CN103038352A Novel intergenic elements for enhancing gene expression |
| 04/10/2013 | CN103038351A Vitronectin:keratinocyte growth factor chimeras |
| 04/10/2013 | CN103038350A Cloning and exploitation of a functional R-gene from solanum X edinense |